Invention Grant
- Patent Title: Antibodies against human RYK and uses therefor
-
Application No.: US14781195Application Date: 2014-04-02
-
Publication No.: US09862776B2Publication Date: 2018-01-09
- Inventor: Maria Luisa Macheda , Michael Maurice Halford , Steven Stacker , Clare Louise Parish , Edouard Collins Nice
- Applicant: Peter MacCallum Cancer Institute
- Applicant Address: AU East Melbourne
- Assignee: Peter MacCallum Cancer Institute
- Current Assignee: Peter MacCallum Cancer Institute
- Current Assignee Address: AU East Melbourne
- Agency: Cesari and McKenna, LLP
- Priority: AU2013901150 20130403
- International Application: PCT/AU2014/000353 WO 20140402
- International Announcement: WO2014/161037 WO 20141009
- Main IPC: C07K16/28
- IPC: C07K16/28 ; C07K16/40 ; G01N33/574

Abstract:
The present invention relates to antibodies and antigen-binding fragments thereof that bind RYK, in particular human RYK and their use in regulating RYK-associated activities. Specifically there is provided an isolated monoclonal antibody or antigen-binding fragment or derivative thereof that specifically binds to the extracellular domain of human RYK, in particular, the antibody or antigen-binding fragment thereof, binds specifically to the WIF domain of human RYK. Preferably, the antibodies of the present invention modulate RYK-associated activity, which includes RYK mediated signal transduction activity and modulation of the interaction of Wnts with RYK and, preferably, modulate Wnt induced signaling. In particular, the antibodies inhibit the binding of Wnt5a and inhibit Wnt induced phosphorylation of Dishevelled (Dvl) 2 and/or Dvl3 proteins.
Public/Granted literature
- US20160053022A1 ANTIBODIES AGAINST HUMAN RYK AND USES THEREFOR Public/Granted day:2016-02-25
Information query